Zotefoams (LON:ZTF) had its price target upped by Canaccord Genuity from GBX 550 ($7.60) to GBX 570 ($7.88) in a research note released on Wednesday. The brokerage currently has a buy rating on the stock.
Shares of Zotefoams (LON ZTF) opened at GBX 515.90 ($7.13) on Wednesday. The firm has a market cap of $229.13 and a PE ratio of 3,685.00. Zotefoams has a fifty-two week low of GBX 280 ($3.87) and a fifty-two week high of GBX 532 ($7.35).
In other Zotefoams news, insider Doug Robertson acquired 5,416 shares of the business’s stock in a transaction on Wednesday, December 20th. The shares were acquired at an average price of GBX 459 ($6.34) per share, for a total transaction of £24,859.44 ($34,345.73). In the last 90 days, insiders acquired 5,483 shares of company stock worth $2,515,772.
ILLEGAL ACTIVITY NOTICE: This news story was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.thelincolnianonline.com/2018/03/15/zotefoams-ztf-price-target-increased-to-gbx-570-by-analysts-at-canaccord-genuity.html.
Zotefoams Company Profile
Zotefoams plc is a United Kingdom-based cellular material technology company. The Company is engaged in the manufacture and sale of cross-linked block foams. The Company’s segments include Polyolefins, High-Performance Products (HPP) and MuCell Extrusion LLC (MEL). Polyolefins foams are made from olefinic homopolymer and copolymer resin.
Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.